Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast
Azenta, Inc. (Nasdaq: AZTA) will release its fiscal Q4 and full year 2022 earnings on November 14, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Azenta, Inc. (Nasdaq: AZTA) will release its fiscal Q4 and full year 2022 earnings on November 14, 2022, after market close. A conference call will follow at 4:30 p.m. ET for analysts and investors, with access via phone and a live webcast on Azenta's website. The firm specializes in life sciences solutions and has recently rebranded from Brooks Automation. Azenta is focused on cold-chain sample management, drug development, and advanced cell therapies, operating globally across North America, Europe, and Asia.
Positive
- Anticipation of Q4 and full year earnings may indicate growth potential.
- The transition from Brooks Automation to Azenta could enhance brand recognition and market reach.
Negative
- None.
Details
News Market Reaction – AZTA
The recorded move for AZTA in the trading session of this news was -0.36%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHELMSFORD, Mass., Nov. 7, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes.
The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, November 14, 2022 at 4:30 p.m. Eastern Time. To participate in the conference call, please dial 800-936-4761 for domestic callers and +1-212-231-2922 for international callers.
Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:30 a.m. ET on November 15, 2022.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As of December 1st, the company changed its name and ticker to Azenta, Inc. (Nasdaq: AZTA) from Brooks Automation, Inc, (Nasdaq: BRKS).
Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations
978.262.2635
ir@azenta.com
Sherry Dinsmore
978.262.2400
sherry.dinsmore@azenta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-announces-fiscal-2022-fourth-quarter-and-full-year-earnings-conference-call-and-webcast-301670797.html
SOURCE Azenta, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.